Mutation and polymorphism analysis in the tuberous sclerosis 2 (TSC2) gene
β Scribed by J. R. Gilbert; V. Guy; A. Kumar; C. Wolpert; R. Kandt; A. Aylesworth; A. D. Roses; M. A. Pericak-Vance
- Publisher
- Springer
- Year
- 1998
- Tongue
- English
- Weight
- 204 KB
- Volume
- 1
- Category
- Article
- ISSN
- 1364-6745
No coin nor oath required. For personal study only.
π SIMILAR VOLUMES
Tuberous sclerosis complex (TSC) is an autosomal dominant disorder characterized by the development of multiple hamartomas involving many organs. About two-thirds of the cases are sporadic and appear to represent new mutations. With the cloning of two causative genes, TSC1 and TSC2 it is now possibl
Tuberous sclerosis complex (TSC) is a severe autosomal-dominant disorder characterized by the development of benign tumors (hamartomas) in many organs. It can lead to intellectual handicap, epilepsy, autism, and renal or heart failure. An inactivating mutation in either of two tumor-suppressor genes
## Communicated by David W. Yandell Tuberous sclerosis complex (TSC) is a dominantly inherited multisystem disorder resulting in the development of hamartomatous growths in many organs. Genetic heterogeneity has been demonstrated linking the familial cases to either TSC1 at 9q34.3, or TSC2 at 16p1
The effects of missense changes and small in-frame deletions and insertions on protein function are not easy to predict, and the identification of such variants in individuals at risk of a genetic disease can complicate genetic counselling. One option is to perform functional tests to assess whether